Company: PSTV
Filing Date: 2025-08-04
Form Type: DRS
Source: 0000950123-25-006916
Chunk: 43

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-08-04
Form: DRS
Chunk 43
---
 for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling
persons, we have been informed that in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

29

Confidential Treatment Requested by Plus Therapeutics, Inc.

Pursuant to 17 C.F.R. Section 200.83

33,000,000 Shares of Common Stock

PROSPECTUS

, 2025

Confidential Treatment Requested by Plus Therapeutics, Inc. Pursuant to 17 C.F.R. Section 200.83 PART II Information Not Required in Prospectus

| Item 13. | Other Expenses of Issuance and Distribution. |

The following is a statement of estimated expenses in connection with the offering described in this registration statement. All expenses incurred with respect to the registration of the common stock will be borne by us. All amounts are estimates except the SEC registration fee.

|                              |     | Amount |        |
|:-----------------------------|:----|:-------|-------:|
| SEC registration fee         |     | $      |    [●] |
| Printing Expenses            |     | $      | 30,000 |
| Legal Fees and Expenses      |     | $      | 35,000 |
| Accounting Fees and Expenses |     | $      | 25,000 |
| Miscellaneous Expenses       |     | $      |    [●] |
| Total                        |     | $      |    [●] |

| Item 14. | Indemnification of Directors and Officers. |

Section 102 of the Delaware General Corporation Law (the “DGCL”) allows a corporation to eliminate the personal liability of directors of a corporation to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except where the director breached the duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of the DGCL or obtained an improper personal benefit. Section 145 of the DGCL provides, among other things, that we may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding—other than an action by or in our right—by reason of the fact that the person is or was our director, officer, agent or employee